Hypoxic Tumor Kinase Signaling Mediated by STAT5A in Development of Castration-Resistant Prostate Cancer

• Kathrine Røe ,

  * E-mail: Kathrine.Roe@ahus.no

  Affiliations Department of Oncology, Akershus University Hospital, Lørenskog, Norway, Department of Clinical Molecular Biology and Laboratory Sciences, Akershus University Hospital, Lørenskog, Norway, Department of Radiation Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

  ⨯
• Åse Bratland,

  Affiliation Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

  ⨯
• Ljiljana Vlatkovic,

  Affiliation Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

  ⨯
• Harald Bull Ragnum,

  Affiliations Department of Radiation Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

  ⨯
• Marie Grøn Saelen,

  Affiliations Department of Tumor Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

  ⨯
• Dag Rune Olsen,

  Affiliation Faculty of Mathematics and Natural Sciences, University of Bergen, Bergen, Norway

  ⨯
• Laure Marignol,

  Affiliation Prostate Molecular Oncology Research Group, Academic Unit of Clinical and Molecular Oncology, Institute of Molecular Medicine, St. James’s Hospital and Trinity College, Dublin, Ireland

  ⨯
• Anne Hansen Ree

  Affiliations Department of Oncology, Akershus University Hospital, Lørenskog, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

  ⨯